Mokhir A - Search Results

1

Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils.

Reshetnikov V, Hahn J, Maueröder C, Czegley C, Munoz LE, Herrmann M, Hoffmann MH, Mokhir A. Reshetnikov V, et al. Among authors: mokhir a. Front Immunol. 2018 Aug 13;9:1827. doi: 10.3389/fimmu.2018.01827. eCollection 2018. Front Immunol. 2018. PMID: 30150984 Free PMC article. Review.

2

Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells.

Marzenell P, Hagen H, Sellner L, Zenz T, Grinyte R, Pavlov V, Daum S, Mokhir A. Marzenell P, et al. Among authors: mokhir a. J Med Chem. 2013 Sep 12;56(17):6935-44. doi: 10.1021/jm400754c. Epub 2013 Aug 26. J Med Chem. 2013. PMID: 23931109

3

Activity of aminoferrocene-based prodrugs against prostate cancer.

Schikora M, Reznikov A, Chaykovskaya L, Sachinska O, Polyakova L, Mokhir A. Schikora M, et al. Among authors: mokhir a. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3447-50. doi: 10.1016/j.bmcl.2015.07.013. Epub 2015 Jul 11. Bioorg Med Chem Lett. 2015. PMID: 26206503

4

Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt^IV Prodrugs.

Reshetnikov V, Daum S, Mokhir A. Reshetnikov V, et al. Among authors: mokhir a. Chemistry. 2017 Apr 27;23(24):5678-5681. doi: 10.1002/chem.201701192. Epub 2017 Apr 5. Chemistry. 2017. PMID: 28319647

5

Lysosome-Targeting Amplifiers of Reactive Oxygen Species as Anticancer Prodrugs.

Daum S, Reshetnikov MSV, Sisa M, Dumych T, Lootsik MD, Bilyy R, Bila E, Janko C, Alexiou C, Herrmann M, Sellner L, Mokhir A. Daum S, et al. Among authors: mokhir a. Angew Chem Int Ed Engl. 2017 Dec 4;56(49):15545-15549. doi: 10.1002/anie.201706585. Epub 2017 Nov 9. Angew Chem Int Ed Engl. 2017. PMID: 28994179

6

A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.

Reshetnikov V , Arkhypov A , Julakanti PR , Mokhir A . Reshetnikov V , et al. Among authors: mokhir a. Dalton Trans. 2018 May 15;47(19):6679-6682. doi: 10.1039/c8dt01458b. Dalton Trans. 2018. PMID: 29708261

7

ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria.

Reshetnikov V, Daum S, Janko C, Karawacka W, Tietze R, Alexiou C, Paryzhak S, Dumych T, Bilyy R, Tripal P, Schmid B, Palmisano R, Mokhir A. Reshetnikov V, et al. Among authors: mokhir a. Angew Chem Int Ed Engl. 2018 Sep 10;57(37):11943-11946. doi: 10.1002/anie.201805955. Epub 2018 Aug 20. Angew Chem Int Ed Engl. 2018. PMID: 30035345

8

Radiosynthesis of an ¹⁸ F-fluoroglycosylated aminoferrocene for in-vivo imaging of reactive oxygen species activity by PET.

Toms J, Reshetnikov V, Maschauer S, Mokhir A, Prante O. Toms J, et al. Among authors: mokhir a. J Labelled Comp Radiopharm. 2018 Dec;61(14):1081-1088. doi: 10.1002/jlcr.3687. Epub 2018 Oct 18. J Labelled Comp Radiopharm. 2018. PMID: 30303563

9

Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with ¹⁸F.

Daum S, Toms J, Reshetnikov V, Özkan HG, Hampel F, Maschauer S, Hakimioun A, Beierlein F, Sellner L, Schmitt M, Prante O, Mokhir A. Daum S, et al. Among authors: mokhir a. Bioconjug Chem. 2019 Apr 17;30(4):1077-1086. doi: 10.1021/acs.bioconjchem.9b00019. Epub 2019 Mar 13. Bioconjug Chem. 2019. PMID: 30768258

10

NOX2 mediates quiescent handling of dead cell remnants in phagocytes.

Hahn J, Euler M, Kilgus E, Kienhöfer D, Stoof J, Knopf J, Hahn M, Harrer T, Hultqvist M, Olofsson P, Mokhir A, Holmdahl R, Herrmann M, Schett G, Muñoz LE, Hoffmann MH. Hahn J, et al. Among authors: mokhir a. Redox Biol. 2019 Sep;26:101279. doi: 10.1016/j.redox.2019.101279. Epub 2019 Jul 20. Redox Biol. 2019. PMID: 31349119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page